OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 02, 2016
Growth may be slowing, but outsourcing activity remains healthy.
Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses how to report quality metrics to FDA.
With deadlines only a few years away, some companies have not started serialization programs, while others are taking a tactical, short-term approach, losing out on potential business benefits.
MilliporeSigma, the North American life-sciences business of Germany’s Merck KGaA, added a 2000-L single-use bioreactor to its facility in Massachusetts.
April 08, 2016
WellSpring Pharma formed a strategic partnership with IDT Australia and invested $3 million in new equipment.
April 02, 2016
A program for calibration and routine testing of weighing instruments ensures accurate results.
Transferring the manufacturing of a drug from one scale to another or between manufacturing sites presents both technical and business challenges.
Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.
Demand is driving expansion and consolidation of formulation and clinical trial materials services.
April 01, 2016
At DCAT's annual meeting, Bill Downey, president of the market research firm High Tech Business Decisions, summarized results from its latest survey on biopharmaceutical outsourcing.